METHOCARBAMOL tablet, coated

Ország: Egyesült Államok

Nyelv: angol

Forrás: NLM (National Library of Medicine)

Vedd Meg Most

Termékjellemzők Termékjellemzők (SPC)
27-08-2019

Aktív összetevők:

METHOCARBAMOL (UNII: 125OD7737X) (METHOCARBAMOL - UNII:125OD7737X)

Beszerezhető a:

Direct_Rx

Az alkalmazás módja:

ORAL

Recept típusa:

PRESCRIPTION DRUG

Terápiás javallatok:

Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man. Methocarbamol tablets are contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components.

Termék összefoglaló:

Methocarbamol tablets, USP 500 mg are light orange colored, roundshaped film coated tablets debossed with "G" above the score line onone side and "500" on other side. They are supplied as follows Bottles of 24 tablets Bottles of 100 tablets N Bottles of 500 tablets Bottles of 1000 tablets Methocarbamol tablets, USP 750 mg are light orange colored, capletshaped film coated tablets debossed with "G" on one side and"750" on other side. Bottles of 24 tablets Bottles of 100 tablets Bottles of 500 tablets Bottles of 1000 tablets Store between 20ºC and 25ºC (68ºF and 77º F) [see USP Controlled Room Temperature]. Dispense in tight container. Manufactured for: Granules USA, Inc. Parsippany, NJ 07054 Toll-free: 1-877-770-3183 Manufactured by: Granules India Limited Hyderabad-500 081 Made in India Issued: January 2017

Engedélyezési státusz:

Abbreviated New Drug Application

Termékjellemzők

                                METHOCARBAMOL- METHOCARBAMOL TABLET, COATED
DIRECT_RX
----------
METHOCARBAMOL 750MG
Methocarbamol tablet, USP, a carbamate derivative of guaifenesin, is a
central nervous system (CNS)
depressant with sedative and musculoskeletal relaxant properties.
The chemical name of methocarbamol is
1,2-Propanediol,3-(2-methoxyphenoxy)-,1-Carbamate,(±)-.(or)
(±)-3-(o-Methoxyphenoxy)-1,2-Propanediol 1-carbamate and has the
empirical formula C11H15NO5. Its
molecular weight is 241.24g/mol. The structural formula is shown
below.
[str]
Methocarbamol is a white powder, sparingly soluble in water and in
chloroform, soluble in alcohol
(only with heating), insoluble in benzene and in n-hexane.
Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets
for oral administration.
Methocarbamol tablets, USP 500 mg are light orange colored, round
shaped film coated tablets
debossed with "G" above the score line on one side and "500" on other
side.
Methocarbamol tablets, USP 750 mg are light orange colored, caplet
shaped film coated tablets
debossed with "G" on one side and "750" on other side.
Methocarbamol tablets, USP 500 mg and 750 mg contain the following
inactive ingredients: colloidal
silicon dioxide, maize starch, povidone, sodium lauryl sulfate, sodium
starch glycolate, and stearic acid.
The tabets are coated with Aquarius Prime which contains FD&C yellow
6, hydroxypropylcellulose,
hypromellose, polysorbate 80, propylene glycol, and titanium dioxide
The mechanism of action of methocarbamol in humans has not been
established, but may be due to
general central nervous system (CNS) depression. It has no direct
action on the contractile mechanism
of striated muscle, the motor end plate or the nerve fiber.
Pharmacokinetics
In healthy volunteers, the plasma clearance of methocarbamol ranges
between 0.20 and 0.80 L/h/kg, the
mean plasma elimination half-life ranges between 1 and 2 hours, and
the plasma protein binding ranges
between 46% and 50%.
Methocarbamol is metabolized via dealkylation and hydroxylation.
Conjugation of m
                                
                                Olvassa el a teljes dokumentumot
                                
                            

A termékkel kapcsolatos riasztások keresése

Dokumentumelőzmények megtekintése